Scholar Rock Holding buy Raymond James
Start price
03.03.26
/
50%
€38.20
Target price
03.03.27
-
Performance (%)
0.00%
Price
03.03.26
€38.20
Summary
This prediction is currently active. Raymond_James's BUY prediction for Scholar Rock Holding is currently unchanged. This prediction currently runs until 03.03.27. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Scholar Rock Holding | 0.00% |
| iShares Core DAX® | -1.306% |
| iShares Nasdaq 100 | 1.979% |
| iShares Nikkei 225® | 0.593% |
| iShares S&P 500 | 1.425% |
Comments by Raymond_James for this prediction
In the thread Scholar Rock Holding diskutieren
Scholar Rock (SRRK) had its "strong-buy" rating reaffirmed by Raymond James Financial, Inc..
Ratings data for SRRK provided by MarketBeat
Stopped prediction by Raymond_James for Scholar Rock Holding
Scholar Rock Holding
Start price
Target price
Perf. (%)
€33.40
30.07.25
30.07.25
€45.82
30.07.26
30.07.26
14.37%
03.03.26
03.03.26
Scholar Rock Holding
Start price
Target price
Perf. (%)
€14.70
28.03.24
28.03.24
€27.73
28.03.25
28.03.25
104.08%
29.03.25
29.03.25